301 related articles for article (PubMed ID: 23056207)
1. Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer.
Coffey K; Blackburn TJ; Cook S; Golding BT; Griffin RJ; Hardcastle IR; Hewitt L; Huberman K; McNeill HV; Newell DR; Roche C; Ryan-Munden CA; Watson A; Robson CN
PLoS One; 2012; 7(10):e45539. PubMed ID: 23056207
[TBL] [Abstract][Full Text] [Related]
2. Regulation of TIP60 by ATF2 modulates ATM activation.
Bhoumik A; Singha N; O'Connell MJ; Ronai ZA
J Biol Chem; 2008 Jun; 283(25):17605-14. PubMed ID: 18397884
[TBL] [Abstract][Full Text] [Related]
3. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM.
Sun Y; Jiang X; Chen S; Fernandes N; Price BD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13182-7. PubMed ID: 16141325
[TBL] [Abstract][Full Text] [Related]
4. Bisbenzamidine derivative, pentamidine represses DNA damage response through inhibition of histone H2A acetylation.
Kobayashi J; Kato A; Ota Y; Ohba R; Komatsu K
Mol Cancer; 2010 Feb; 9():34. PubMed ID: 20144237
[TBL] [Abstract][Full Text] [Related]
5. Histone acetyltransferase promotes fluoride toxicity in LS8 cells.
Deng H; Fujiwara N; Cui H; Whitford GM; Bartlett JD; Suzuki M
Chemosphere; 2020 May; 247():125825. PubMed ID: 31927229
[TBL] [Abstract][Full Text] [Related]
6. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
7. KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling.
Kaidi A; Jackson SP
Nature; 2013 Jun; 498(7452):70-4. PubMed ID: 23708966
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells.
Collins HM; Abdelghany MK; Messmer M; Yue B; Deeves SE; Kindle KB; Mantelingu K; Aslam A; Winkler GS; Kundu TK; Heery DM
BMC Cancer; 2013 Jan; 13():37. PubMed ID: 23356739
[TBL] [Abstract][Full Text] [Related]
9. Rational design and validation of a Tip60 histone acetyltransferase inhibitor.
Gao C; Bourke E; Scobie M; Famme MA; Koolmeister T; Helleday T; Eriksson LA; Lowndes NF; Brown JA
Sci Rep; 2014 Jun; 4():5372. PubMed ID: 24947938
[TBL] [Abstract][Full Text] [Related]
10. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity.
Stimson L; Rowlands MG; Newbatt YM; Smith NF; Raynaud FI; Rogers P; Bavetsias V; Gorsuch S; Jarman M; Bannister A; Kouzarides T; McDonald E; Workman P; Aherne GW
Mol Cancer Ther; 2005 Oct; 4(10):1521-32. PubMed ID: 16227401
[TBL] [Abstract][Full Text] [Related]
11. Tip60 in DNA damage response and growth control: many tricks in one HAT.
Squatrito M; Gorrini C; Amati B
Trends Cell Biol; 2006 Sep; 16(9):433-42. PubMed ID: 16904321
[TBL] [Abstract][Full Text] [Related]
12. The FATC domains of PIKK proteins are functionally equivalent and participate in the Tip60-dependent activation of DNA-PKcs and ATM.
Jiang X; Sun Y; Chen S; Roy K; Price BD
J Biol Chem; 2006 Jun; 281(23):15741-6. PubMed ID: 16603769
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation.
Sun Y; Jiang X; Chen S; Price BD
FEBS Lett; 2006 Aug; 580(18):4353-6. PubMed ID: 16844118
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer using KAT inhibitors to mimic lethal knockouts.
Brown JA; Bourke E; Eriksson LA; Kerin MJ
Biochem Soc Trans; 2016 Aug; 44(4):979-86. PubMed ID: 27528742
[TBL] [Abstract][Full Text] [Related]
15. p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress.
Eymin B; Claverie P; Salon C; Leduc C; Col E; Brambilla E; Khochbin S; Gazzeri S
Mol Cell Biol; 2006 Jun; 26(11):4339-50. PubMed ID: 16705183
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathways.
Kranz D; Dohmesen C; Dobbelstein M
J Cell Biol; 2008 Jul; 182(1):197-213. PubMed ID: 18625847
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2.
Carlessi L; Buscemi G; Larson G; Hong Z; Wu JZ; Delia D
Mol Cancer Ther; 2007 Mar; 6(3):935-44. PubMed ID: 17363488
[TBL] [Abstract][Full Text] [Related]
18. A bivalent role of TIP60 histone acetyl transferase in human cancer.
Judes G; Rifaï K; Ngollo M; Daures M; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
Epigenomics; 2015; 7(8):1351-63. PubMed ID: 26638912
[TBL] [Abstract][Full Text] [Related]
19. Axin determines cell fate by controlling the p53 activation threshold after DNA damage.
Li Q; Lin S; Wang X; Lian G; Lu Z; Guo H; Ruan K; Wang Y; Ye Z; Han J; Lin SC
Nat Cell Biol; 2009 Sep; 11(9):1128-34. PubMed ID: 19731416
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells.
Agarwal C; Tyagi A; Agarwal R
Mol Cancer Ther; 2006 Dec; 5(12):3294-302. PubMed ID: 17172433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
